相关实验视频

Updated: Jan 17, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

通过全基因组测序来测定骨髓瘤瘤的端粒含量和基因组学

Luca Guarnera^1,2, Adam Wahida³, Carmelo Gurnari^1,2

¹Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH.

|September 22, 2025

概括

端粒含量 (TC) 在髓质瘤瘤 (MN) 中降低,变异与特定的遗传突变和细胞起源有关. 这一发现为在MN疗法中准端粒维持提供了一个基准.

科学领域:

血液学血液学血液学
基因组学就是基因组学.
癌症生物学癌症生物学

背景情况:

端粒长度缩短与髓质瘤瘤 (MN) 中的基因组不稳定性有关.
缺少系统性研究,将端粒含量 (TC) 与大型MN队列中的分子特征相关联.

研究的目的:

在一大群骨髓瘤 (MN) 患者中调查端粒含量 (TC).
将TC与特定的分子特征相关联,包括突变和转录组学.
为验证一种基于全基因组测序的新方法来确定TC.

主要方法:

利用一种基于全基因组测序的新,交叉验证的方法来确定端粒含量 (TC).
分析了一大群 (N = 1804) 患有MN的患者,包括急性髓性白血病 (AML) 和骨髓发育综合征.
与突变相关联的TC,转录组学和功能测试.

主要成果:

与健康个体相比,骨髓瘤瘤 (MN) 和克隆性非恶性疾病显示端粒含量 (TC) 降低.
成年人MN的TC较低,并且不依赖年龄,子类型之间存在显著差异.
急性髓性白血病 (AML) 呈现最低的TC;成熟细胞起源或RAS通路突变与较低的TC相关.
具有TP53突变或复杂型的mn显示相对保留TC,与端粒酶活性相关,而不是替代延长.

结论:

建立了一个基因型特定的端粒构成为一个大的mn队列.
确定了与特定的MN亚型和遗传改变相关的独特TC模式.
提供了一个分子基准,用于未来的治疗向MN的端粒机械.

更多相关视频

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on: April 5, 2018

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

相关概念视频

Genomics

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

Telomeres and Telomerase

Telomeres and Telomerase